Annexon, Inc. (ANNX) stock
ANNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.52+0.05 (+1.44%)
Close on Nov 18, 2026Market cap $719.65MP/E –Yield 0.00%
Annexon operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Annexon's operating income for the twelve months ending Jun 30, 2026 was -$210.56M. For fiscal 2025 it was -$216.41M. The highest annual figure on record is -$32.52M in fiscal 2019.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$216.41M | – |
| FY2024 | Dec 31, 2024 | -$154.07M | – |
| FY2023 | Dec 31, 2023 | -$143.72M | – |
| FY2022 | Dec 31, 2022 | -$145.60M | – |
| FY2021 | Dec 31, 2021 | -$130.71M | – |
| FY2020 | Dec 31, 2020 | -$63.47M | – |
| FY2019 | Dec 31, 2019 | -$32.52M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$57.23M | – |
| Q1 FY2026 | Mar 31, 2026 | -$46.05M | – |
| Q4 FY2025 | Dec 31, 2025 | -$50.26M | – |
| Q3 FY2025 | Sep 30, 2025 | -$57.02M | – |
| Q2 FY2025 | Jun 30, 2025 | -$51.73M | – |
| Q1 FY2025 | Mar 31, 2025 | -$57.41M | – |
| Q4 FY2024 | Dec 31, 2024 | -$52.48M | – |
| Q3 FY2024 | Sep 30, 2024 | -$39.44M | – |
| Q2 FY2024 | Jun 30, 2024 | -$33.58M | – |
| Q1 FY2024 | Mar 31, 2024 | -$28.57M | – |
| Q4 FY2023 | Dec 31, 2023 | -$30.01M | – |
| Q3 FY2023 | Sep 30, 2023 | -$34.78M | – |
| Q2 FY2023 | Jun 30, 2023 | -$37.69M | – |
| Q1 FY2023 | Mar 31, 2023 | -$41.24M | – |
| Q4 FY2022 | Dec 31, 2022 | -$36.70M | – |
| Q3 FY2022 | Sep 30, 2022 | -$36.07M | – |
| Q2 FY2022 | Jun 30, 2022 | -$37.41M | – |
| Q1 FY2022 | Mar 31, 2022 | -$35.43M | – |
| Q4 FY2021 | Dec 31, 2021 | -$37.46M | – |
| Q3 FY2021 | Sep 30, 2021 | -$35.68M | – |
| Q2 FY2021 | Jun 30, 2021 | -$31.37M | – |
| Q1 FY2021 | Mar 31, 2021 | -$26.20M | – |
| Q4 FY2020 | Dec 31, 2020 | -$23.19M | – |
| Q3 FY2020 | Sep 30, 2020 | -$15.59M | – |
| Q2 FY2020 | Jun 30, 2020 | -$12.24M | – |
| Q1 FY2020 | Mar 31, 2020 | -$12.46M | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.13M | – |
| Q3 FY2019 | Sep 30, 2019 | -$9.07M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.22M | – |
See a number that looks wrong?